atezolizumab
roche
['imvigor-130', 'atezo']
dr. presented a post-hoc analysis of imvigor-130 comparing ct+atezo vs ct+placebo in those patients with no-pd at 18wks, simulating a javelin population. unfortunately, still negative for maintenance atezo. #asco23 
Medical oncologist at @BPorgbr. Former fellow of GU oncology @DanaFarber @Harvard @MOCbrasil. #GUcancer